Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.५१%
१,१००.७५
-५.६१
-०.५१%
—१,१०६.३६१,१०५.६८१,१०९.२९१,०९६.५२——
SIXC
Communications
SIXC
Communications
SIXC
+०.४५%
६१३.०१
+२.७२
+०.४५%
—६१०.२९६१०.२९६१६.६०६१०.२९——
SIXE
Energy
SIXE
Energy
SIXE
+०.८०%
१,२२०.८७
+९.६५
+०.८०%
—१,२११.२२१,२११.०११,२२२.३६१,२०८.५०——
SIXI
Industrials
SIXI
Industrials
SIXI
+०.४१%
१,७५७.९२
+७.२१
+०.४१%
—१,७५०.७११,७५३.१०१,७६२.१३१,७४३.३०——
SIXM
Financials
SIXM
Financials
SIXM
+०.७०%
६३२.५८
+४.४१
+०.७०%
—६२८.१७६२९.३८६३४.०९६२९.३८——
SIXR
Staples
SIXR
Staples
SIXR
+०.२९%
८५७.०५
+२.४८
+०.२९%
—८५४.५७८५५.७१८६०.०९८५५.४५——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.४५%
२१५.९०
-०.९७
-०.४५%
—२१६.८७२१६.८७२१७.७९२१५.५१——
SIXT
Technology
SIXT
Technology
SIXT
+१.६१%
३,६१९.३४
+५७.४०
+१.६१%
—३,५६१.९४३,५७१.४४३,६२८.५८३,५६२.१५——
SIXU
Utilities
SIXU
Utilities
SIXU
+०.२३%
९०५.३५
+२.०४
+०.२३%
—९०३.३१९०३.२६९०७.२५९०१.१८——
SIXV
Health care
SIXV
Health care
SIXV
-०.१०%
१,४८०.११
-१.४३
-०.१०%
—१,४८१.५४१,४८२.४८१,४८८.४६१,४७४.१८——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.०६%
२,४०१.३१
+१.३६
+०.०६%
—२,३९९.९५२,४०४.४५२,४१८.८१२,३९८.०९——
ALNOV:EPA
Novacyt SA
€ ०.५२
-१८.७५%
(-०.१२) 1D
मे १४, १७:३५:१० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALNOV...
Open
€ ०.५८
High
€ ०.६०
Low
€ ०.५०
Mkt. cap
३.७२ करोड
Avg. vol.
१२.०१ लाख
Volume
५३.४८ लाख
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२१६
News stories
From sources across the web
PIX11
PIX11
·
१७ मिनेट पहिले
Cisco leads Wall Street toward more records and the Dow back to 50,000
Fox Business
Fox Business
·
२१ मिनेट पहिले
Bull market roars back on strong earnings momentum
Yahoo! Finance Canada
Yahoo! Finance Canada
·
३३ मिनेट पहिले
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
The Motley Fool
The Motley Fool
·
१ घण्टा पहिले
The Battle of iShares ETFs: Should You Buy the S&P 500 ETF or Russell 2000?
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees२१६
Founded२००६ जुलाई ३
Headquarters-
Sector-
Websitenovacyt.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
४८.९६ लाख
४८.९६ लाख
५१.१८ लाख
५१.१८ लाख
Cost of goods sold
१६.४३ लाख
१६.४३ लाख
२०.६४ लाख
२०.६४ लाख
Cost of revenue
१६.४३ लाख
१६.४३ लाख
२०.६४ लाख
२०.६४ लाख
Research and development expenses
१०.२२ लाख
१०.२२ लाख
१०.३४ लाख
१०.३४ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.०८ लाख
५५.०८ लाख
५२.३८ लाख
५२.३८ लाख
Operating expense
६४.३२ लाख
६४.३२ लाख
१.४१ करोड
१.४१ करोड
Total operating expenses
८०.७५ लाख
८०.७५ लाख
१.६२ करोड
१.६२ करोड
Operating income
-३१.७८ लाख
-३१.७८ लाख
-१.११ करोड
-१.११ करोड
Other non operating income
-३१.०० हजार
-३१.०० हजार
२६.७४ लाख
२६.७४ लाख
EBT including unusual items
-३५.१३ लाख
-३५.१३ लाख
-१.०२ करोड
-१.०२ करोड
EBT excluding unusual items
-३१.२० लाख
-३१.२० लाख
-१.०६ करोड
-१.०६ करोड
Income tax expense
-१.३४ लाख
-१.३४ लाख
-१८.१४ लाख
-१८.१४ लाख
Effective tax rate
३.८०%
३.८०%
१७.८५%
१७.८५%
Other operating expenses
-९७.५० हजार
-९७.५० हजार
७८.५५ लाख
७८.५५ लाख
Net income
-३१.७१ लाख
-३१.७१ लाख
-८२.७० लाख
-८२.७० लाख
Net profit margin
-६४.७६%
-६४.७६%
-१६१.६०%
-१६१.६०%
Earnings per share
-
-
-
-
Interest and investment income
१.७७ लाख
१.७७ लाख
-
-
Interest expense
-१.५४ लाख
-१.५४ लाख
-२०.८६ लाख
-२०.८६ लाख
Net interest expenses
२३.०० हजार
२३.०० हजार
-२०.८६ लाख
-२०.८६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२१.६६ लाख
-२१.६६ लाख
-२८.०४ लाख
-२८.०४ लाख
Gain or loss from assets sale
-१.४८ लाख
-१.४८ लाख
-३.०० हजार
-३.०० हजार
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer